(Q39195699)

English

Dose-ranging study of the new beta-adrenergic antagonist nadolol in the treatment of essential hypertension

scientific article published on January 1, 1978

Statements

Dose-ranging study of the new beta-adrenergic antagonist nadolol in the treatment of essential hypertension (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit